Lanean...
Targeting Ras signaling in AML: RALB is a small GTPase with big potential
Acute myeloid leukemia (AML) is a devastating malignancy for which novel treatment approaches are desperately needed. Ras signaling is an attractive therapeutic target for AML because a large proportion of AMLs have mutations in NRAS, KRAS, or genes that activate Ras signaling, and key Ras effectors...
Gorde:
| Argitaratua izan da: | Small GTPases |
|---|---|
| Egile Nagusiak: | , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Taylor & Francis
2017
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6959283/ https://ncbi.nlm.nih.gov/pubmed/28682649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21541248.2017.1339765 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|